Natali, Eriberto Noel http://orcid.org/0000-0002-9100-807X
Horst, Alexander
Meier, Patrick http://orcid.org/0000-0002-8585-6208
Greiff, Victor http://orcid.org/0000-0003-2622-5032
Nuvolone, Mario http://orcid.org/0000-0001-8334-1684
Babrak, Lmar Marie
Fink, Katja http://orcid.org/0000-0002-3571-0390
Miho, Enkelejda http://orcid.org/0000-0001-6461-0519
Funding for this research was provided by:
Wellcome Trust (215840/Z/19/Z, 215840/Z/19/Z, 215840/Z/19/Z, 215840/Z/19/Z)
Article History
Received: 1 December 2022
Accepted: 7 December 2023
First Online: 20 January 2024
Change Date: 13 February 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41541-024-00820-4
Competing interests
: Network algorithms for computational antibody discovery pipelines implemented in this publication are part of the aiNET discovery pipeline. Prof. Dr. Enkelejda Miho is the founder, managing director and owns shares in aiNET GmbH. Prof. Dr. Victor Greiff is in the scientific advisory board of aiNET GmbH.